These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 1879447)

  • 61. Radiopharmaceuticals for bone lesions. Imaging and therapy in clinical practice.
    Pauwels EK; Stokkel MP
    Q J Nucl Med; 2001 Mar; 45(1):18-26. PubMed ID: 11456371
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Radionuclide therapy of malignant and benign extra-thyroid diseases].
    zum Winkel K
    Onkologie; 1982 Apr; 5(2):67-75. PubMed ID: 6285243
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Somatostatin receptors as targets for nuclear medicine imaging and radionuclide treatment.
    Maecke HR; Reubi JC
    J Nucl Med; 2011 Jun; 52(6):841-4. PubMed ID: 21571797
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Radionuclide therapy in oncology: the dawning of its concomitant use with other modalities?
    Valdés Olmos RA; Hoefnagel CA
    Eur J Nucl Med Mol Imaging; 2004 Jul; 31(7):929-31. PubMed ID: 15042326
    [No Abstract]   [Full Text] [Related]  

  • 65. Treatment of non-Hodgkin's lymphoma (NHL) with radiolabeled antibodies (mAbs).
    DeNardo GL
    Semin Nucl Med; 2005 Jul; 35(3):202-11. PubMed ID: 16098294
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Molecular targeting with radionuclides: state of the science.
    Britz-Cunningham SH; Adelstein SJ
    J Nucl Med; 2003 Dec; 44(12):1945-61. PubMed ID: 14660721
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Therapeutic radiopharmaceuticals.
    Ercan MT; Caglar M
    Curr Pharm Des; 2000 Jul; 6(11):1085-121. PubMed ID: 10903384
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Receptor radionuclide therapy of tumors: a road from basic research to clinical applications.
    Bodei L; Paganelli G; Mariani G
    J Nucl Med; 2006 Mar; 47(3):375-7. PubMed ID: 16513604
    [No Abstract]   [Full Text] [Related]  

  • 69. An overview of the diagnostic and therapeutic use of monoclonal antibodies in medicine.
    Goldsmith SJ; Signore A
    Q J Nucl Med Mol Imaging; 2010 Dec; 54(6):574-81. PubMed ID: 21221066
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Comparison of high-dose rate prostate brachytherapy dose distributions with iridium-192, ytterbium-169, and thulium-170 sources.
    Krishnamurthy D; Weinberg V; Cunha JA; Hsu IC; Pouliot J
    Brachytherapy; 2011; 10(6):461-5. PubMed ID: 21397569
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Antibody-based targeted radiation to pediatric tumors.
    Modak S; Cheung NK
    J Nucl Med; 2005 Jan; 46 Suppl 1():157S-63S. PubMed ID: 15653664
    [TBL] [Abstract][Full Text] [Related]  

  • 72. AAPM TG-43U1 formalism adaptation and monte carlo dosimetry simulations of multiple-radionuclide brachytherapy sources.
    Nuttens VE; Lucas S
    Med Phys; 2006 Apr; 33(4):1101-7. PubMed ID: 16696487
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The management of painful bone metastases with an emphasis on radionuclide therapy.
    Hillegonds DJ; Franklin S; Shelton DK; Vijayakumar S; Vijayakumar V
    J Natl Med Assoc; 2007 Jul; 99(7):785-94. PubMed ID: 17668645
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Clinical trial design and scoring of radionuclide therapy endpoints: normal organ toxicity and tumor response.
    Meredith R
    Cancer Biother Radiopharm; 2002 Feb; 17(1):83-99. PubMed ID: 11915176
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Targeting radiation to tumours.
    Wheldon TE
    Int J Radiat Biol; 1994 Jan; 65(1):109-16. PubMed ID: 7905903
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Radionuclide studies in surgical oncology.
    Sundram FX
    Ann Acad Med Singap; 1988 Jan; 17(1):113-7. PubMed ID: 3056217
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Radiotheranostics in endocrinology and oncoendocrinology].
    Rumyanstsev RO
    Probl Endokrinol (Mosk); 2021 Feb; 67(1):8-12. PubMed ID: 33586387
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Applied principles of radiopharmaceutical use in therapy.
    Spencer RP
    Int J Rad Appl Instrum B; 1986; 13(4):461-3. PubMed ID: 3793503
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response.
    Smith TAD
    Genes (Basel); 2024 May; 15(6):. PubMed ID: 38927624
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The increasing potential of nuclear medicine imaging for the evaluation and reduction of normal tissue toxicity from radiation treatments.
    Mohan V; Bruin NM; van de Kamer JB; Sonke JJ; Vogel WV
    Eur J Nucl Med Mol Imaging; 2021 Nov; 48(12):3762-3775. PubMed ID: 33687522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.